CIK 0001285550 · Non-accelerated filer<br>Smaller reporting company
ClearPoint Neuro, Inc.
Sign in to watch- Ticker
- CLPT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582394628
- Phone
- 9499006833
- Business address
- 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH, CA, 92075
- Former names
- MRI INTERVENTIONS, INC., SURGIVISION INC, SURGI VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | FLETCHER R JOHN Director | Grant or award | +850 | $6.80 | $6K | 74,797 |
| 2024-04-01 | Girin Pascal E R Director | Grant or award | +1,056 | $6.80 | $7K | 55,044 |
| 2024-04-01 | LIAU LINDA M. Director | Grant or award | +436 | $6.80 | $3K | 13,131 |
| 2024-04-01 | Richards Timothy T. Director | Grant or award | +1,640 | $6.80 | $11K | 44,408 |
| 2024-03-11 | STIGALL L. JEREMY Chief Business Officer | Grant or award · Restricted Stock Units | +16,583 | 16,583 | ||
| 2024-03-11 | D'Alessandro Danilo Chief Financial Officer | Grant or award · Restricted Stock Units | +8,291 | 8,291 | ||
| 2024-03-06 | SABRA MAZIN Chief Operating Officer | Option exercise | +6,913 | 47,352 | ||
| 2024-03-06 | SABRA MAZIN Chief Operating Officer | Shares withheld for taxes | −3,463 | $6.24 | $22K | 43,889 |
| 2024-03-06 | SABRA MAZIN Chief Operating Officer | Option exercise · Restricted Stock Units | −6,913 | 27,654 | ||
| 2024-03-06 | STIGALL L. JEREMY Chief Business Officer | Option exercise | +8,889 | 50,874 | ||
| 2024-03-06 | STIGALL L. JEREMY Chief Business Officer | Shares withheld for taxes | −3,180 | $6.24 | $20K | 47,694 |
| 2024-03-06 | STIGALL L. JEREMY Chief Business Officer | Option exercise · Restricted Stock Units | −8,889 | 35,555 | ||
| 2024-03-06 | D'Alessandro Danilo Chief Financial Officer | Option exercise | +9,383 | 58,312 | ||
| 2024-03-06 | D'Alessandro Danilo Chief Financial Officer | Shares withheld for taxes | −4,718 | $6.24 | $29K | 53,594 |
| 2024-03-06 | D'Alessandro Danilo Chief Financial Officer | Option exercise · Restricted Stock Units | −9,383 | 37,530 | ||
| 2024-03-06 | BURNETT JOSEPH MICHAEL CEO and President | Option exercise | +23,704 | 274,430 | ||
| 2024-03-06 | BURNETT JOSEPH MICHAEL CEO and President | Shares withheld for taxes | −11,066 | $6.24 | $69K | 263,364 |
| 2024-03-06 | BURNETT JOSEPH MICHAEL CEO and President | Option exercise · Restricted Stock Units | −23,704 | 94,814 | ||
| 2024-02-22 | STIGALL L. JEREMY GM, Biologics & Drug Delivery | Shares withheld for taxes | −1,039 | $7.49 | $8K | 41,985 |
| 2024-01-02 | Richards Timothy T. Director | Grant or award | +1,643 | $6.79 | $11K | 42,768 |
Page 13 of 15 · 296 trades